Mei-Chee Tai

828 total citations
15 papers, 285 citations indexed

About

Mei-Chee Tai is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Mei-Chee Tai has authored 15 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Mei-Chee Tai's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (3 papers). Mei-Chee Tai is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (3 papers). Mei-Chee Tai collaborates with scholars based in Malaysia, Japan and United States. Mei-Chee Tai's co-authors include Ichidai Tanaka, Ayumu Taguchi, Delphine Daydé, Rekha Jain, Takashi Takahashi, Masahiro Nakatochi, Yukako Shimada, Taisuke Kajino, Motoshi Suzuki and Kiyoshi Yanagisawa and has published in prestigious journals such as Nature Cell Biology, Cancer Research and Scientific Reports.

In The Last Decade

Mei-Chee Tai

13 papers receiving 285 citations

Peers

Mei-Chee Tai
Melissa Lazar United States
Xinwei Yun China
Anna Bellmunt Spain
Patricia Borges de Souza Italy
Xiaoding Liu China
Zining Jin China
Priyanka Bhateja United States
C.F.J.M. Blanken-Peeters Netherlands
Dechuang Jiao China
Melissa Lazar United States
Mei-Chee Tai
Citations per year, relative to Mei-Chee Tai Mei-Chee Tai (= 1×) peers Melissa Lazar

Countries citing papers authored by Mei-Chee Tai

Since Specialization
Citations

This map shows the geographic impact of Mei-Chee Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei-Chee Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei-Chee Tai more than expected).

Fields of papers citing papers by Mei-Chee Tai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei-Chee Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei-Chee Tai. The network helps show where Mei-Chee Tai may publish in the future.

Co-authorship network of co-authors of Mei-Chee Tai

This figure shows the co-authorship network connecting the top 25 collaborators of Mei-Chee Tai. A scholar is included among the top collaborators of Mei-Chee Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei-Chee Tai. Mei-Chee Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Treekitkarnmongkol, Warapen, Mei-Chee Tai, Sanchita Rauth, et al.. (2025). RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer. Nature Cell Biology. 28(1). 197–206.
2.
Tai, Mei-Chee, Leonidas E. Bantis, Ichidai Tanaka, et al.. (2024). Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma. International Journal of Molecular Sciences. 25(4). 2331–2331.
3.
Mariapun, Shivaani, Weang-Kee Ho, Mikael Eriksson, et al.. (2023). Evaluation of SNPs associated with mammographic density in European women with mammographic density in Asian women from South-East Asia. Breast Cancer Research and Treatment. 201(2). 237–245. 1 indexed citations
4.
Dittmar, Rachel L., Suyu Liu, Mei-Chee Tai, et al.. (2021). Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. Cancer Prevention Research. 14(7). 729–740. 27 indexed citations
5.
Wang, Huixue, Jie Yang, Hui Pan, et al.. (2020). <p>Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway</p>. OncoTargets and Therapy. Volume 13. 3903–3920. 8 indexed citations
6.
Kajino, Taisuke, Mei-Chee Tai, Zhuoran Liu, et al.. (2017). Thyroid transcription factor‐1‐regulated micro RNA ‐532‐5p targets KRAS and MKL 2 oncogenes and induces apoptosis in lung adenocarcinoma cells. Cancer Science. 108(7). 1394–1404. 28 indexed citations
7.
Tai, Mei-Chee, Yat‐Yuen Lim, Ping Chong Bee, et al.. (2017). SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression. Scientific Reports. 7(1). 41400–41400. 4 indexed citations
8.
Daydé, Delphine, Ichidai Tanaka, Rekha Jain, Mei-Chee Tai, & Ayumu Taguchi. (2017). Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer. International Journal of Molecular Sciences. 18(3). 573–573. 129 indexed citations
9.
Kajino, Taisuke, Mei-Chee Tai, Zhuoran Liu, et al.. (2017). Abstract 2529: TTF-1/NKX2-1 induced miR-532-5p targets KRAS and MKL2 oncogenes and causes apoptosis in lung adenocarcinoma cells. Cancer Research. 77(13_Supplement). 2529–2529. 2 indexed citations
10.
Tai, Mei-Chee, Taisuke Kajino, Masahiro Nakatochi, et al.. (2016). miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Journal of Thoracic Oncology. 11(2). S48–S48. 8 indexed citations
11.
Tai, Mei-Chee, Kiyoshi Yanagisawa, Masahiro Nakatochi, et al.. (2016). Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma. Scientific Reports. 6(1). 31389–31389. 19 indexed citations
12.
Tai, Mei-Chee, Taisuke Kajino, Masahiro Nakatochi, et al.. (2015). miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis. 36(12). bgv152–bgv152. 43 indexed citations
13.
Gan, Gin Gin, et al.. (2014). Impact of Inadequate Doses of Rituximab in the Treatment of Diffuse Large B Cell Lymphoma in Malaysian Patients. Asian Pacific Journal of Cancer Prevention. 15(4). 1703–1706. 3 indexed citations
14.
Lim, Yat‐Yuen, et al.. (2014). Analysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population. Leukemia & lymphoma. 56(1). 163–168. 10 indexed citations
15.
Gan, Gin Gin, et al.. (2012). Allele and Genotype frequencies of VKORC1 -1639G>A polymorphism in three different ethnic groups in Malaysia. 20(1). 19–23. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa Lazar Breakdown of academic impact, for papers by Xinwei Yun Breakdown of academic impact, for papers by Anna Bellmunt Breakdown of academic impact, for papers by Patricia Borges de Souza Breakdown of academic impact, for papers by Xiaoding Liu Breakdown of academic impact, for papers by Zining Jin Breakdown of academic impact, for papers by Priyanka Bhateja Breakdown of academic impact, for papers by C.F.J.M. Blanken-Peeters Breakdown of academic impact, for papers by Dechuang Jiao
Rankless by CCL
2026